Duality Advisers, LP Intra Cellular Therapies, Inc. Transaction History

Duality Advisers, LP

  • $0
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023
BUY
$54.67 - $66.44 $1.79 Million - $2.18 Million
32,805 New
32,805 $2.08 Million
Q4 2022

Feb 07, 2023
SELL
$44.07 - $54.45 $1.33 Million - $1.65 Million
-30,273 Reduced 55.98%
23,809 $1.26 Million
Q3 2022

Nov 03, 2022
BUY
$42.7 - $59.99 $96,373 - $135,397
2,257 Added 4.36%
54,082 $2.52 Million
Q2 2022

Aug 08, 2022
BUY
$43.0 - $65.64 $2.23 Million - $3.4 Million
51,825 New
51,825 $2.96 Million

Others Institutions Holding ITCI

# of Institutions
416
Shares Held
88.5M
Call Options Held
284K
Put Options Held
105K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.1B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email